207 related articles for article (PubMed ID: 31260066)
1. Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism.
Kitahara CM; Berrington de Gonzalez A; Bouville A; Brill AB; Doody MM; Melo DR; Simon SL; Sosa JA; Tulchinsky M; Villoing D; Preston DL
JAMA Intern Med; 2019 Aug; 179(8):1034-1042. PubMed ID: 31260066
[TBL] [Abstract][Full Text] [Related]
2. Association of Radioactive Iodine, Antithyroid Drug, and Surgical Treatments With Solid Cancer Mortality in Patients With Hyperthyroidism.
Kitahara CM; Preston DL; Sosa JA; Berrington de Gonzalez A
JAMA Netw Open; 2020 Jul; 3(7):e209660. PubMed ID: 32701159
[TBL] [Abstract][Full Text] [Related]
3. Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: A Systematic Review and Meta-analysis.
Shim SR; Kitahara CM; Cha ES; Kim SJ; Bang YJ; Lee WJ
JAMA Netw Open; 2021 Sep; 4(9):e2125072. PubMed ID: 34533571
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
5. Solid cancer incidence in atomic bomb survivors: 1958-1998.
Preston DL; Ron E; Tokuoka S; Funamoto S; Nishi N; Soda M; Mabuchi K; Kodama K
Radiat Res; 2007 Jul; 168(1):1-64. PubMed ID: 17722996
[TBL] [Abstract][Full Text] [Related]
6. Associating radioiodine therapy in hyperthyroidism with cancer mortality: robust or random results of a statistical analysis?
Iakovou I; Giannoula E; Chatzipavlidou V; Sachpekidis C
Hell J Nucl Med; 2020; 23(1):94-95. PubMed ID: 32361719
[TBL] [Abstract][Full Text] [Related]
7. Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group.
Ron E; Doody MM; Becker DV; Brill AB; Curtis RE; Goldman MB; Harris BS; Hoffman DA; McConahey WM; Maxon HR; Preston-Martin S; Warshauer ME; Wong FL; Boice JD
JAMA; 1998 Jul 22-29; 280(4):347-55. PubMed ID: 9686552
[TBL] [Abstract][Full Text] [Related]
8. Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma.
Corrêa NL; de Sá LV; de Mello RC
Thyroid; 2017 Feb; 27(2):261-270. PubMed ID: 27762670
[TBL] [Abstract][Full Text] [Related]
9. Radiation doses and cancer risks in the Marshall Islands associated with exposure to radioactive fallout from Bikini and Enewetak nuclear weapons tests: summary.
Simon SL; Bouville A; Land CE; Beck HL
Health Phys; 2010 Aug; 99(2):105-23. PubMed ID: 20622547
[TBL] [Abstract][Full Text] [Related]
10. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.
Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K
Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Fixed Dose Radioactive Iodine (RAI) for the Treatment of Hyperthyroidism: Experience of a Teaching Hospital in South West Nigeria.
Enyi Ejeh M J; Omotayo Ogunjobi K; Enyi Ejeh J; Solomon Adedapo K; F Eniojukan J
Mol Imaging Radionucl Ther; 2013 Aug; 22(2):36-41. PubMed ID: 24003395
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of radioactive iodine treatment of graves' hyperthyroidism using a single calculated
Wong KK; Shulkin BL; Gross MD; Avram AM
Clin Diabetes Endocrinol; 2018; 4():20. PubMed ID: 30505461
[TBL] [Abstract][Full Text] [Related]
14. Patient-specific anatomical models for radioiodine dosimetry in treatment of hyperthyroidism: is it necessary?
Khalili S; Miri-Hakimabad H; Hoseinian-Azghadi E
Med Phys; 2020 Oct; 47(10):5357-5365. PubMed ID: 32790906
[TBL] [Abstract][Full Text] [Related]
15. The feasibility of low-dose oral lithium therapy and its effect on thyroidal radioiodine uptake, retention, and hormonal parameters in various subcategories of hyperthyroid patients: a pilot study.
Chouhan A; Abhyankar A; Basu S
Nucl Med Commun; 2016 Jan; 37(1):74-8. PubMed ID: 26465804
[TBL] [Abstract][Full Text] [Related]
16. Cure Rates After a Single Dose of Radioactive Iodine to Treat Hyperthyroidism: The Fixed-Dose Regimen.
Madu NM; Skinner C; Oyibo SO
Cureus; 2022 Aug; 14(8):e28316. PubMed ID: 36039121
[TBL] [Abstract][Full Text] [Related]
17. Organ Dose Estimates for Hyperthyroid Patients Treated with (131)I: An Update of the Thyrotoxicosis Follow-Up Study.
Melo DR; Brill AB; Zanzonico P; Vicini P; Moroz B; Kwon D; Lamart S; Brenner A; Bouville A; Simon SL
Radiat Res; 2015 Dec; 184(6):595-610. PubMed ID: 26579944
[TBL] [Abstract][Full Text] [Related]
18. Increased cancer incidence after radioiodine treatment for hyperthyroidism.
Metso S; Auvinen A; Huhtala H; Salmi J; Oksala H; Jaatinen P
Cancer; 2007 May; 109(10):1972-9. PubMed ID: 17393376
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.
Erem C; Kandemir N; Hacihasanoglu A; Ersöz HO; Ukinc K; Kocak M
Endocrine; 2004 Oct; 25(1):55-60. PubMed ID: 15545707
[TBL] [Abstract][Full Text] [Related]
20. Relationship between follow-up periods and the low-dose ranges with statistically significant radiation-induced risk of all solid cancers in the Russian cohort of Chernobyl emergency workers.
Ivanov VK; Karpenko SV; Kashcheev VV; Lovachev SS; Kashcheeva PV; Shchukina NV; Tumanov KA; Kochergina EV; Maksioutov MA
Radiat Environ Biophys; 2020 Aug; 59(3):415-421. PubMed ID: 32468176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
